InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Ludlum Ken, 董事. Officer active across 5 companies, notably Personalis, Inc.. Aggregated, 7 disclosures have been published. Activity tracked since 14 May 2021. The latest transaction was disclosed on 14 June 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Ludlum Ken
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
52,817 股@ €1.3506100.0% 占其流量Class A Common StockSEC:0001493152-24-049259:0
39,267 股@ US$1.91100.0% 占其流量Common StockSEC:0001209191-23-037568:0
27,472 股0Common StockSEC:0001209191-22-037554:0
10,770 股0Common StockSEC:0001209191-22-030753:0
5,420 股0Common StockSEC:0001209191-21-042268:0
2,736 股0Common StockSEC:0001209191-21-033492:0
11,000 股Common StockSEC:0000899243-16-012215:0
7 条申报中的 7 条
About Ludlum Ken
Ken Ludlum is a Director at Personalis, Inc. and IRIDEX Corp. As a board member, he participates in the governance and strategy of both companies, bringing his expertise in the biotechnology field.
